It’s been a busy year at Intouch! In addition to growing new business and making sure we meet our existing clients’ needs, we’ve also worked hard to keep you in the loop about what matters and what not to worry about in our industry. Over the past 12 months, our subject matter experts have covered everything from social media trends to regulatory issues. So, before we put 2015 behind us, let’s look back one more time at our top 10 most-read posts.

Google Says No More Exceptions for Pharma Paid Search Ads (POV)

  • This post on Google’s decision to discontinue two paid search types was our most-read post of 2015, and it continues to be a must-read today. Get background info and our recommendations about these important changes, one of which is set to take effect on January 12, 2016.

5 Reasons Pharma Should Reconsider Instagram

  • Intouch social media manager Jennifer Starr discusses the rise of visual content as the preferred method of message delivery and lays out five reasons pharma needs to use Instagram to reach audiences.

Google Chrome Update: The Fall of Flash

  • Google announced in September that it would disable Flash-based banner ads on its Chrome browser if users were not engaging with them. In this post, we address the consequences for pharma and provide recommendations for mitigating negative impacts.

Firms Apply Programmatic Media Buying and Predictive Targeting for Astounding Results

  • U.S. advertisers embraced programmatic media buying in 2015, yet the healthcare industry has been slow to get in the game due to privacy barriers. Learn about what Intouch is doing to make this new playing field accessible to pharma in this post from Intouch EVP Angela Tenuta and Crossix VP Shannon Gallagher.

FDA Updates Guidance on Submitting Promotional Materials Electronically

  • Back in April, the FDA issued a draft guidance, “Providing Regulatory Submissions in Electronic and Non-Electronic Format—Promotional Labeling and Advertising Materials for Human Prescription Drugs Guidance for Industry,” that affects the submission of all promotional materials (whether final sample, for advisory comments or other) to the FDA. Many aspects of the guidance have a direct impact on existing marketing and marketing services operations. This post summarizes the FDA-required changes and offers recommendations on how to comply.

We Know He’s a Healthcare Transformer; Now It’s Official

  • Intouch CEO Faruk Capan was named one of Medical Marketing & Media’s Top 40 Healthcare Transformers this year. Read more about our fearless leader.

Health Apps and Wearables: The Future of Pharma

  • Wearables and apps have the ability to give people more information about their day-to-day health so they can make better choices overall. This post looks at what’s happening with wearables, what pharma needs to consider when developing health apps, and how to succeed in this market.

The Legend of the One-Click Rule Poised to Become Reality

  • If the one-click rule becomes a reality, it’ll be a game changer for digital marketing. The rule would allow digital ads to display an “introductory paragraph” about a medical product — like its name and approved uses — without extra info about safety and effectiveness, if the safety information is available via hyperlink. We don’t know yet if this will come to pass, but until then, check out this post to learn more about its implications for pharma.

SXSW Interactive 2015: Ideas, Intrigue and Pure Inspiration

  • Intouch took South by Southwest Interactive (SXSWi) by storm in 2015! This post highlights popular sessions and some of the activities Intouchers participated in during the festival.

Millennials as Parents: Your Healthcare Messaging Is Outdated

  • Marketers can’t afford to write off Millennials as an insignificant audience with no buying power. On the contrary, Millennial consumers are engaged, health-conscious decision makers with a great deal of influence on their families and peers. Read this informative post to learn about four things Millennials look for when they make brand decisions.